CompuGroup Medical SE & Co. KGaA (COP) — Strategic Asset Allocation Index
CompuGroup Medical SE & Co. KGaA (COP) has a Strategic Asset Allocation Index of 23.5% as of June 2023. Strategic assets (PP&E of €159.68 Million plus long-term investments of €-) total €159.68 Million, measured against net assets of €679.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See COP net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
CompuGroup Medical SE & Co. KGaA Strategic Asset Allocation Index (2013–2022)
This chart shows how CompuGroup Medical SE & Co. KGaA's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 23.5%, representing strategic assets of €159.68 Million against net assets of €679.87 Million EUR. For live market cap and overall valuation, see CompuGroup Medical SE & Co. KGaA (COP) market capitalisation.
Annual Strategic Asset Allocation Index for CompuGroup Medical SE & Co. KGaA (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for CompuGroup Medical SE & Co. KGaA from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See CompuGroup Medical SE & Co. KGaA (COP) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 23.9% | €160.89 Million | €160.89 Million | €- | €673.82 Million | ▼ -1.9 pp |
| 2021 | 25.8% | €158.00 Million | €158.00 Million | €- | €612.28 Million | ▲ +4.5 pp |
| 2020 | 21.3% | €136.29 Million | €136.29 Million | €- | €638.94 Million | ▼ -30.5 pp |
| 2019 | 51.8% | €134.71 Million | €131.25 Million | €3.46 Million | €259.92 Million | ▲ +17.4 pp |
| 2018 | 34.5% | €94.09 Million | €83.65 Million | €10.44 Million | €273.00 Million | ▼ -5.2 pp |
| 2017 | 39.7% | €93.75 Million | €82.81 Million | €10.94 Million | €236.06 Million | ▲ +3.7 pp |
| 2016 | 36.0% | €78.75 Million | €73.85 Million | €4.90 Million | €218.65 Million | ▲ +2.9 pp |
| 2015 | 33.1% | €63.84 Million | €60.39 Million | €3.45 Million | €192.61 Million | ▼ -2.9 pp |
| 2014 | 36.0% | €63.23 Million | €62.05 Million | €1.18 Million | €175.63 Million | ▲ +0.4 pp |
| 2013 | 35.6% | €68.56 Million | €61.22 Million | €7.33 Million | €192.64 Million | — |